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We surveyed the populations of 19 European coun-
tries to compare the prevalence of antimicrobial drug self-
medication in the previous 12 months and intended
self-medication and storage and to identify the associated
demographic characteristics. By using a multistage sam-
pling design, 1,000–3,000 adults in each country were ran-
domly selected. The prevalence of actual self-medication
varied from 1 to 210 per 1,000 and intended self-medica-
tion from 73 to 449 per 1,000; both rates were high in east-
ern and southern Europe and low in northern and western
Europe. The most common reasons for self-medication
were throat symptoms (e.g., dry, inflamed, red, or sore
throat, inflamed tonsils, tonsil pain). The main medication
sources were pharmacies and medication leftover from
previous prescriptions. Younger age, higher education, and
presence of a chronic disease were associated with higher
rates of self-medication. Attempts to reduce inappropriate
self-medication should target prescribers, pharmacists, and
the general public. 
Antimicrobial drug resistance is a rapidly increasingglobal problem (1,2), and prevalence varying widely
among countries (3). Prevalence of resistance is positively
correlated with prescribed outpatient drug use on a nation-
al level (4,5). However, actual consumption of drugs may
also include self-medication, i.e., using drugs obtained
without prescription. Other sources of self-medication may
include leftover drugs from treatment courses prescribed
earlier or drugs obtained from relatives or friends. Use
without medical guidance is inappropriate because using
insufficient dosages or incorrect or unnecessary drugs
increases the risk of the selection of resistant bacteria (6)
and the spread of antimicrobial drug resistance (7).
To date, the information on self-medication with
antimicrobial drugs in the industrialized world is limited.
In the United States, several studies indicate considerable
use of leftovers (8–10), drugs obtained from a family
member, a pharmacy, or a source outside the country
(11,12). For example, in an Hispanic neighborhood of New
York City, antimicrobial drugs are available without a pre-
scription (13). In Europe, studies describing self-medica-
tion and storage of antimicrobial drugs in Spain (14,15),
Greece (16,17), Russia (18), and Malta (19) also suggest
considerable use of the drugs without consulting a physi-
cian. However, these studies were small or used selected
samples and were not carried out in northern and western
Europe. Moreover, because of the different research meth-
ods used, no meaningful comparison between countries
was possible. In addition, little information exists on fac-
tors that puts person at-risk for self-medication. This sur-
vey was designed to fill that gap for 19 European
countries: Austria, the Netherlands, Sweden, United
Kingdom, Ireland, Denmark, Italy, Malta, Luxembourg,
Belgium, Spain, Israel, Romania, Czech Republic,
Slovakia, Lithuania, Slovenia, Croatia, and Poland. The
aim of this study was to estimate and compare the preva-
lence of actual self-medication and at-risk for self-medica-
tion with antimicrobial drugs in participating countries.
The demographic characteristics associated with such use,
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the types of drugs used, the sources of self-medication, the
symptoms for which the drugs were reportedly used, and
duration of use were also examined.
Methods
Countries participating in the study were recruited from
2 networks of surveillance systems: European Surveillance
of Antimicrobial Consumption (20) and European
Antimicrobial Resistance Surveillance System (21). A
multistage sampling design was used for sample selection
in each participating country. Within each country, a region
with average prescribed antimicrobial drug consumption
was chosen. In those countries where this information was
not available (Poland, Czech Republic, Lithuania, Croatia,
and Romania), a region was selected that was representa-
tive of the country’s population in terms of age and sex. In
each region, a city (75,000−750,000 inhabitants) and a
rural area (5,000−10,000) were selected. By using popula-
tion registries, including lists of persons in the identified
cities and rural areas, persons >18 years of age were select-
ed by simple random sampling (computer-generated ran-
dom numbers). To calculate the sample size, we needed the
standard deviation of the unknown prevalence. As the stan-
dard deviation was a function of this unknown prevalence,
we took the maximal possible value of the standard devia-
tion (22). To obtain a precision of 0.05, the sample size
needed was 400 persons per country. To adjust for possible
nonresponse, we selected larger samples; sample sizes in
the countries were 1,000–3,000 persons, equally distrib-
uted in urban and rural areas. Self-administered question-
naires were mailed between March and July 2003, and
reminders with a new questionnaire attached were sent 2−
4 weeks later. 
We developed an English questionnaire specifically for
this survey, translated it into national languages, and back-
translated it to ensure consistency.1 The questionnaire was
pilot-tested in each country. It could be completed either
anonymously or with identifiable details to allow a follow-
up study. Questions asked about the respondent’s use of
antimicrobial drugs during the past 12 months, how they
were obtained, how they were stored at home, and whether
the respondent would consider using drugs without con-
sulting a physician. Details of the drugs used (name of the
medicine, symptom or disease coded with International
Classification of Primary Care codes [23], and duration of
use) and demographic characteristics of the respondents
were included. Antibacterial drugs for systemic use
(Anatomical Therapeutic Chemical class J01) (24) were
included in the analyses. Medicines erroneously reported
as antimicrobial drugs were excluded from the analyses.
Ethics or data committee approval for the survey was
required in Sweden, Denmark, Belgium, United Kingdom,
Ireland, Malta, Czech Republic, Slovenia, Croatia,
Romania, and Lithuania and was obtained from the local
ethics or data committees of these countries. 
Respondents were classified as self-medicating if they
reported that they had taken any antimicrobial drugs in the
previous 12 months without a prescription from a physi-
cian, dentist, or nurse and as prescribed users if antimicro-
bial drugs had been prescribed. (Physician respondents
who reported using nonprescribed drugs were not classi-
fied as self-medicating.) Those classified as at-risk for
self-medication included those who indicated the intention
to self-medicate or store drugs at home. Intended self-med-
ication was defined as answering “yes” or “maybe” to the
question, “In general, would you use antimicrobial drugs
for yourself without contacting a doctor/nurse/hospital?”
Two estimates were used to assess storage of drugs: a max-
imum estimate, including all respondents who stored
antimicrobial drugs, and a conservative estimate that
excluded those respondents who stored antimicrobial
drugs and had taken the same drugs for a prescribed course
in the previous 12 months. 
Statistical Analyses
Descriptive statistics were used to estimate the preva-
lence rates per 1,000 respondents and 95% confidence
intervals (CI) for actual self-medication and prescribed use
in the previous 12 months and for at-risk self-medication
in each country. To assess possible bias from low response
rates, we also estimated adjusted prevalence rates. We
applied the continuum of the resistance model (25), based
on the assumption that late respondents most resemble
nonrespondents. Late respondents in our study were those
who replied after the reminder. The adjusted prevalence is
considered similar to the observed prevalence when it falls
in the 95% CI of the observed prevalence. 
The effects of individual characteristics and country on
antimicrobial drug self-medication were studied with logis-
tic regression analyses by using 3 outcome variables: actu-
al self-medication in the previous 12 months, storage of
antimicrobial drugs, and intended self-medication.
Countries were grouped together in 3 European regions:
northern and western (Sweden, Denmark, the Netherlands,
Austria, Belgium, Luxemburg, United Kingdom, and
Ireland), southern (Malta, Italy, Israel, and Spain), and east-
ern (Czech Republic, Slovenia, Croatia, Poland, Slovakia,
Romania, and Lithuania). This grouping was based on pat-
terns of prescribed use of antimicrobial drugs (4), geo-
graphic location (26), similarities in healthcare systems,
and socioeconomic development. The former socialist
countries are referred to as eastern countries. We tested pos-
sible interactions between the factors found to be
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author on request.
significant and set the significance at p<0.01 for interaction
terms due to multiple testing. Multivariate logistic regres-
sion was also used to study the relationship between intend-
ed self-medication, storage, and actual self-medication in
the previous 12 months. Data were analyzed by using SPSS
(version 11) for Windows (SPSS Inc, Chicago, IL, USA).
Results
A total of 15,548 respondents completed the question-
naires. The mean response rate of the countries was 40%
(Table 1).
Prevalence of Self-medication and Prescribed Use 
The prevalence rates of antimicrobial drug self-medica-
tion (actual and at-risk) and prescribed use are presented
separately for countries with response rates >40% and
<40% (Table 2). In both of these groups, prevalence rates
for actual self-medication were highest in eastern (in par-
ticular, Romania and Lithuania), followed by rates in
southern (Malta, Spain, and Italy) Europe. The lowest rates
were in northern and western (the Netherlands and
Sweden) Europe. The rates of at-risk self-medication also
tended to be higher in southern and eastern Europe than in
northern and western Europe. The adjusted estimates of
prevalence rates of self-medication were similar to the
observed rates for many of the countries.2 In Luxembourg,
Austria, Israel, Spain, and Lithuania, the adjusted rates of
self-medication were consistently higher than the observed
rates, indicating that the observed rates may underestimate
the prevalence in these countries. By contrast, in Romania,
Croatia, and Slovenia, the adjusted rates were lower than
the observed rates, indicating that the prevalence rates
might be overestimated in our study.
We compared our estimates of antimicrobial drug self-
medication with data available from the European Union’s
Eurobarometer survey in October 2002 (27). We calculat-
ed the prevalence of drug use from “leftovers” and drugs
“directly from the pharmacy” by using the Eurobarometer
data and compared these figures with the same estimates in
our study. The estimates were similar with overlapping
95% CIs (data not shown) for countries with both high and
low response rates. Our figures differed regarding Spain,
for which we found a higher prevalence of self-medication
than did the Eurobarometer. Three other studies (4,15,28)
indicated an even higher prevalence of self-medication in
Spain than in our estimate.
Types of Antimicrobial Drugs Used 
for Self-medication and Duration of Use
Antimicrobial drugs from all classes were used for self-
medication in countries with response rates both >40% and
<40% (information is shown in the online Appendix
Figure, available at http://www.cdc.gov/ncidod/eid/vol12
no03/05-0992_app-G.htm). Penicillins were the most com-
monly used, representing 54% of total courses in all coun-
tries. Among the countries with response rate >40%,
southern and eastern countries used significantly more
broad-spectrum penicillin for self-medication than north-
ern and western countries (χ2, p<0.05). This difference was
significant when the analysis was repeated and included all
countries (χ2, p<0.01). Seventeen courses of self-medica-
tion with chloramphenicol in Lithuania and 1 course in the
Czech Republic were found (data not shown). Ten courses
of self-medication with parenteral (injectable) antimicro-
bial drugs, namely streptomycin or gentamicin, were
found in Lithuania (data not shown). The median duration
of actual self-medication was 5 days (1 to 100 days) and
was significantly longer among the respondents who had
chronic diseases (Mann-Whitney U test, p<0.01).
Reasons for Self-medication and Sources
A throat symptom (including red or sore throat), teeth
or gum symptoms, and bronchitis were the most common
reasons for self-medicating (Figure 1). Eye infection, pain,
prostatitis, urogenital infection, headache, and “bad
health” were among the other reasons for self-medication
(data not shown). In countries with response rates >40%, a
throat symptom was also the most common, followed by
symptoms of the teeth or gums (Figure 1). Symptoms such
as inflammation, skin infection, or diarrhea were reported
only in countries with lower response rates. Self-medica-
tion for pyelonephritis or pyelitis was reported only in
Lithuania; diarrhea was reported in Lithuania (10 patients;
9 used chloramphenicol), Austria (1 patient), and United
Kingdom (1 patient). 
For intended self-medication as with actual self-med-
ication, a sore throat was the most common symptom, fol-
lowed by urinary tract infection and toothache (Figure 2).
When including only those countries that had response
rates >40%, sore throat and urinary tract infection were
also the most common symptoms (Figure 2). 
In eastern countries, the major source of self-medica-
tion was the pharmacy without prescription (309 courses,
68%), followed by leftover medications (120 courses,
26%). By contrast, in southern, northern, and western
countries use of leftover medication was more prevalent
(46 courses [51%] in southern countries and 35 courses
[44%] in northern and western countries), followed by
medications obtained directly from the pharmacy (41
courses [46%] in southern countries and 15 courses [19%]
in northern and western countries). Among other sources
of self-medication were drugs obtained from relatives or
friends (52 courses, 8%, in all countries), drugs that were
RESEARCH
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2The adjusted estimates for each country are available from the
corresponding author on request.
stored after being obtained abroad (10 courses, 2%, in all
countries), and drugs obtained over the Internet (3 courses,
all in Lithuania).
Effects of Individual Characteristics
The effects of demographic characteristics and chronic
disease on actual self-medication, intended self-medica-
tion, and storage of antimicrobial drugs are shown in Table
3. Sex and location (urban or rural) had no significant rel-
evance in any of the 3 models. Respondents from southern
and eastern countries were more likely to self-medicate
(adjusted odds ratio [OR] 6.8, 95% CI 4.8−9.7, and 7.5,
5.7−10.0, respectively) than respondents from northern
and western countries. Younger age, higher educational
level, and presence of a chronic disease were all signifi-
cantly associated with self-medication. Similar results
were obtained for the relationship between demographic
characteristics and storage of antimicrobial drugs, by using
the conservative estimate of storage. Younger age, higher
educational level, and presence of a chronic disease were
also significant predictors of intended self-medication.
Presence of a chronic disease increased the risk of intend-
ed self-medication, but this effect diminished with increas-
ing age. We repeated all analyses including only those
countries that had response rates >40% and obtained simi-
lar results. We also repeated these analyses separately for
early and late respondents and obtained similar results.3
Relation between Intended Self-medication, 
Storage, and Actual Self-medication
Intended self-medication and storage are both predic-
tors of actual self-medication. A significant relationship
was found between intended self-medication and storage.
Intended self-medication was a strong predictor for actual
self-medication for both respondents who stored drugs
(OR 20.9, 95% CI 15.5−28.2) and those who did not (OR
17.8, 95% CI 14.0−22.7). However, for those who did not
intend to self-medicate, storage also predicted higher actu-
al self-medication (OR 3.5, 95% CI 2.2−5.6). When the
analyses were repeated, including only those countries that
had response rates >40%, similar results were obtained.3
Conclusions
Self-medication with antimicrobial drugs occurred in
all countries that participated in this survey. We included
the data from both countries that had high and low
response rates. In most of the countries with low response
rates (except Spain), no other information is available
about self-medication, an often overlooked issue. The sec-
ond reason for including these countries was that low
response was not a problem of this study only, but a gen-
eral problem of surveys in these countries (29,30). This
finding implies that if we want to include information
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about these countries, the results may be biased. In addi-
tion, debate is growing that low response is less problem-
atic in affecting survey estimates than previously assumed
(31). Nevertheless, the prevalence rates of self-medication
in countries with low response rates should be considered
as a rough estimate and interpreted as an indication that the
problem exists.
Antimicrobial drug self-medication prevalence varies
widely among different European regions, with the highest
rates in eastern and southern countries, and the lowest in
northern and western. Besides actual self-medication,
intended self-medication is clearly relevant: it is a strong
predictor of actual self-medication. Intended self-medica-
tion has a much higher prevalence than actual self-medica-
tion, indicating that the population at-risk is much larger
than those who have actually self-medicated in the previ-
ous 12 months. Another risk factor for actual self-medica-
tion is the availability of drugs at home; opportunity
encourages use. Our findings contribute to the growing
evidence that estimates of antimicrobial drug use that are
based on prescription data only are likely to underestimate
actual consumption in both Europe and the United States
(11,32). Our European estimates are low in comparison
with those from a recent study in the US Hispanic commu-
nity that showed that ≈20% of the respondents acknowl-
edged getting drugs without a prescription in the United
States (32). The only comparable high rates were found in
Spain, Romania, and Lithuania, where they ranged from
9% to 18%. However, these figures should be compared
with caution because our estimates refer to acquiring drugs
without prescription in the last 12 months and the United
States study refers to ever acquiring them.
RESEARCH
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We found that many persons used antimicrobial drug
leftovers from previous prescriptions, as was the case in
reports from the United States (8−10,12). Drugs could be
left over because extra tablets were dispensed (in many
countries pharmacies dispense drugs per package, not exact
number of tablets) or because of patient noncompliance.
Noncompliance may result in 2 inappropriate courses if the
patient does not take the amount of medication prescribed
and self-medicates later. Earlier findings indicated lower
compliance in Italy and Spain than in Belgium, France, and
the United Kingdom (33). In Italy, 41% of the interviewees
who had taken drugs in the previous 12 months saved part
of the course for future use, whereas only 4% of British
interviewees reported this behavior (33).
In general, respondents’ self-diagnosed disorders were
self-limiting and antimicrobial drugs would not have been
indicated. In contrast to studies in developing countries,
this study identified few cases of self-medication for sexu-
ally transmitted diseases (34,35). Only 2 respondents in
Lithuania reported self-medication for “gynecological
infection” that might have been a sexually transmitted
infection. 
In this survey, persons who were more prone to self-
medicate with antimicrobial drugs were younger persons,
more educated, and had chronic diseases. This finding cor-
responds to those of studies conducted in the United States
and Greece, which also found that higher educational sta-
tus is associated with misuse of drugs (8,17). This relation-
ship cannot be directly attributed to educational status. The
interpretation of symptoms is also relevant. Previously, a
study in the United States showed that persons with a high-
er education level tended to believe that antimicrobial
drugs were less effective for upper respiratory infections
with clear discharge but more effective with discolored
discharge (36). 
Antimicrobial drug self-medication is a cause for con-
cern because it may contribute to the spread of antimicro-
bial drug resistance. Self-treatment with a drug that is
ineffective against the causative organism or with an inap-
propriate dosage may increase the risk of selection of
resistant organisms that are difficult to eradicate. These
resistant organisms may then be transferred into the com-
munity. Our findings illustrate that adverse effects are
aggravated by self-medication when unnecessary drugs,
such as chloramphenicol, tetracycline, and aminoglyco-
sides, are taken. Other problems related to self-medication
include drug interactions, masked diagnoses, and superin-
fection. 
Our results are comparable to those of other studies
such as the Eurobarometer study (14,19,27). A study on
antimicrobial drug storage among Spanish households
showed that 42% of Spanish households had drugs at
home, including those currently used (14). This finding is
comparable to the prevalence of drugs stored (50%) in our
study. In Malta, a higher prevalence (19%) of self-medica-
tion was found (19) than in our study, perhaps because the
study included self-medication in the previous 2 years,
while our study included the previous 12 months.
Furthermore, the pattern of the prescribed use of drugs in
different regions of Europe in our study is similar to that
found in the study by Goossens et al., which was based on
information from national databases (4). 
A strength of our study is that we used the same meth-
ods and comparable samples in all countries, which facili-
tated an overview of the European situation. The low
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Figure 1. Prevalence of actual self-medication by symptoms or dis-
eases classified by International Classification of Primary Care
codes (rates per 1,000 respondents and 95% confidence interval).
*Symptoms or diseases with rates <1 per 1,000 respondents,
including eye infection, pain, prostatitis, urogenital infection,
headache, and "bad health."
Figure 2. Prevalence of intended self-medication per predefined
symptom (rates per 1,000 respondents and 95% confidence
interval).
response rate in some countries is a limitation of our study,
however. Although we calculated the prevalence rates
adjusted for nonresponse, they are based on the assump-
tion that respondents who replied after the reminder most
resemble nonrespondents.
As with all self-reported data, results of this survey
have the potential for recall bias, underreporting, or over-
reporting. We attached the list of the most commonly used
antimicrobial drugs in each country to the questionnaires
to reduce recall problems. To discourage underreporting of
self-medication, the questions about drug use were formu-
lated in a neutral way in which the source of the drug could
be chosen from 6 predefined sources or “other source.”
Substantial variation in the prevalence rates of antimi-
crobial drug self-medication among the European regions
suggests that cultural (37) and socioeconomic factors play
a role, as do disparities in health care systems such as reim-
bursement policies, access to health care, and drug dis-
pensing policies. Another factor is the acquisition of
antimicrobial drugs from pharmacies without prescription,
which occurred most frequently in eastern European coun-
tries. Although over-the-counter sale of antimicrobial
drugs is illegal in all participating countries, there is clear-
ly a need to enforce the law in some countries.
Antimicrobial drug self-medication is a cause for con-
cern in Europe. Even the lowest prevalence, 1 person per
1,000 respondents, implies that 10,000 persons in a popula-
tion of 10,000,000 are self-medicating annually. Our study
indicates a high prevalence of self-medication in countries
that reported high resistance levels (southern and eastern
countries). Even in the countries with low actual self-med-
ication, substantial intended self-medication and drug stor-
age occurs. Efforts to reduce inappropriate use of anti-
microbial drugs should include the issue of self-medication
and should involve prescribers, pharmacists, and the gener-
al public. The number of tablets dispensed in pharmacies
should be limited, and patients should be instructed to dis-
card their leftover drugs. Large-scale public campaigns,
such as those recently launched in the United States,
Canada, Belgium, and Australia (38), should include
detailed instructions and emphasize the potential risks of
using antimicrobial drugs without medical guidance. 
This study was funded by a grant from DG/Sanco of the
European Commission (SPC2002333), the European
Commission Public Health Directorate DG SANCO, and the par-
ticipating institutions. 
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Groningen, University of Groningen. Her current research interest
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